Development of an indirect enzyme-linked immunosorbent assay (ELISA) to differentiate antibodies against wild-type porcine reproductive and respiratory syndrome from the vaccine strain TJM-F92 based on a recombinant Nsp2 protein

•An ELISA based on the PRRSV modified live vaccine (MLV) TJM-F92 deletion on the Nsp2 was developed.•It distinguishes pigs infected with wild type strains from those vaccinated with MLV TJM-F92.•It has a sensitivity of a sensitivity of 90.7% (98/108) and a specificity of 95.1% (154/162). An accurate...

Full description

Saved in:
Bibliographic Details
Published in:Journal of virological methods Vol. 251; pp. 151 - 154
Main Authors: Wang, X.X., Wang, F.X., Li, Z.G., Wen, Y.J., Wang, X., Song, N., Wu, H.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-01-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•An ELISA based on the PRRSV modified live vaccine (MLV) TJM-F92 deletion on the Nsp2 was developed.•It distinguishes pigs infected with wild type strains from those vaccinated with MLV TJM-F92.•It has a sensitivity of a sensitivity of 90.7% (98/108) and a specificity of 95.1% (154/162). An accurate ELISA method to differentiate pigs infected with wild-type porcine reproductive and respiratory syndrome (PRRSV) strains from vaccinated ones would help to monitor PRRSV vaccination compliance. The recombinant protein GST-d120aa derived from the continuous deletion of 120 amino acids in the non-structural protein 2 region of the modified-live vaccine strain TJM-F92 was used to develop an indirect enzyme-linked immunosorbent assay (d120-ELISA) for differentiating serum antibodies against TJM-F92 from other PRRSV strains. At the optimized cut-off value which was calculated at an S/P of 0.25, it yielded a sensitivity of 90.7% and a specificity of 95.1%. Cross-reactivity tests suggested that the d120-ELISA was PRRSV-specific. Coefficient of variations of the repeatability tests ranged between 1.41–17.02%. The results suggest that the d120-ELISA is suitable for differentiating animals infected with wild-type strains from those immunized with MLV TJM-F92.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0166-0934
1879-0984
DOI:10.1016/j.jviromet.2017.09.001